, and the enlarged bronchiole (black arrowhead) and enlarged alveolar air spaces (black stars) in Fig 5A  correspond to the low-attenuation areas (white arrowhead and white star) in the GGO component of the part-solid nodule on the U-HRCT and C-HRCT images (Fig 5B and 5C ). The lepidic component indicated by the black dots in Fig 5A corresponds to the GGO component (black dot) of the part-solid nodule on the U-HRCT and C-HRCT images (Fig 5B and 5C ). (D) Maximum intensity projection (MIP) image (2 cm thick) of the pulmonary vessels obtained from the U-HRCT data. (E) MIP image (4 cm thick) of the pulmonary vessels obtained from the C-HRCT data. Fine pulmonary vessels are depicted on the MIP image reconstructed from the U-HRCT data (black arrows). The size of the fine pulmonary vessels, as indicated by the black arrows (Fig 5D) , was 0.2 mm. The black star in each MIP image indicates the part-solid nodule of the adenocarcinoma in situ. (F) 3D curved-MPR image of the pulmonary bronchi from the U-HRCT data. (G) 3D curved-MPR image of the pulmonary bronchi from the C-HRCT data. U-HRCT image (Fig 5F) clearly depicting the part-solid opacity (black arrowhead) immediately adjacent to the bronchial wall (white star) with traction bronchiectasis caused by the collapse of the alveoli in the tumor. A: pulmonary artery. V: pulmonary vein. 
